RECRUITING

A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

Talk to us

Conditions

Cancer RiskTissue RepositoryBlood SamplesBiological SamplesSurveysEarly DetectionRisk Assessment

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is not a treatment study. The overall objective is to develop an improved standard of care through studying blood, tissue, biological, etc. samples, that patients have allowed researchers to procure.

Official Title

Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer (ORIEN)

Quick Facts

Study Start:2015-09-16
Study Completion:2037-09
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03617939

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. 18 years of age and older.
  2. 2. Diagnosed with cancer, or may be at risk for cancer.
  3. 3. Able to understand and sign the TCCP Informed Consent and Research Authorization form directly or through a legally authorized representative (LAR).
  1. 1. Members of vulnerable populations including neonates (birth to 30 days), children (under age 18), wards of the State, prisoners or those on probation or alternate sentencing, or decisionally challenged (adults or children that are cognitively impaired, incompetent to consent, proxy consent, or consenting in life threatening situations).

Contacts and Locations

Study Contact

Kyra Anderson
CONTACT
303-724-3868
kyra.anderson@cuanschutz.edu

Principal Investigator

Virginia Borges, MD
PRINCIPAL_INVESTIGATOR
University of Colorado, Denver

Study Locations (Sites)

University of Colorado Hospital
Aurora, Colorado, 80045
United States
UCHealth Memorial Hospital Central
Colorado Springs, Colorado, 80909
United States
UCHealth Memorial Hospital North
Colorado Springs, Colorado, 80909
United States
Cherry Creek Medical Center
Denver, Colorado, 80206
United States
UCHealth Poudre Valley Health System
Fort Collins, Colorado, 80528
United States
Highlands Ranch Medical Center
Highlands Ranch, Colorado, 80126
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • Virginia Borges, MD, PRINCIPAL_INVESTIGATOR, University of Colorado, Denver

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2015-09-16
Study Completion Date2037-09

Study Record Updates

Study Start Date2015-09-16
Study Completion Date2037-09

Terms related to this study

Keywords Provided by Researchers

  • Tissue Repository
  • Blood Samples
  • Biological Samples
  • Surveys
  • Early Detection
  • Risk Assessment

Additional Relevant MeSH Terms

  • Cancer Risk